New daratumumab Phase 2 results posted in stage 3B AL amyloidosis; AFT-19 results still standingNov 13Weekly roundup, 5 itemsapalutamidedaratumumabUpdated
GSK's NASH trial HORIZON completes; malaria and myeloma studies stay in viewNov 13Weekly roundup, 5 itemsbelantamab mafodotinGlaxoSmithKlineUpdated
FDA grants accelerated approval to belantamab mafodotin-blmf for multiple myelomaNov 6Regulatory decisionbelantamabbelantamab mafodotin
Takeda sees ixazomib combo results posted; zasocitinib Phase 2 vitiligo trial activeNov 6Weekly roundup, 4 itemsBristol Myers Squibbixazomib
Merck collaborator posts pancreatic cancer results; new MK-1045, COPD trial records surfaceNov 6Weekly roundup, 14 itemsDaiichi SankyoensifentrineUpdated
Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
IDEAYA completes darovasertib NDA, halts Phase 3 OptimUM-010 for enrollment issuesNov 3Quarterly updateAlector, Inc.Allogene Therapeutics
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
GSK's Benlysta label updated by FDA; Phase 2a NASH trial posts resultsOct 30Weekly roundup, 10 itemsaletekitugAmgenUpdated
Janssen registers Phase 3 TRIlogy-6 trial in newly diagnosed multiple myelomaOct 30Weekly roundup, 5 itemsbosentandaratumumab
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
AstraZeneca completes balcinrenone/dapagliflozin PK study; posts two new observational trialsOct 23Weekly roundup, 12 itemsabemaciclibAstraZeneca
Pfizer registers four studies: elranatamab, berobenatide, tilrekimig, and completed etrasimod trialOct 23Weekly roundup, 14 itemsabrocitinibatirmociclibUpdated
Roche posts HCC trial results, registers five new studies across cancer, MS, flu, COPDSep 18Weekly roundup, 6 itemsbaloxavir marboxilcevostamab
AbbVie sponsors new ABBV-253 solid tumor trial; collaborates on epcoritamab lymphoma studySep 10Weekly roundup, 2 itemsABBV-253AbbVie
AbbVie to acquire Apogee Therapeutics, updates 2026 EPS guidance amid Q2 resultsJul 31Quarterly updateAbbVie
SunRISe-1 bladder cancer trial posts Phase 2b results; TiTan myeloma trial registeredJul 31Weekly roundup, 2 itemsdaratumumabJohnson & Johnson
BMS week: two label updates, new luspatercept CKD trial, pulmonary fibrosis study registeredJul 24Weekly roundup, 6 itemsadagrasibBristol Myers Squibb
Karuna/BMS opens Phase 3 KarXT relapse prevention trial in schizophreniaJul 7Weekly roundup, 2 itemsBristol Myers Squibbpomalidomide
Genmab reports positive Phase 3 results for epcoritamab plus lenalidomide in DLBCLJun 29Clinical readoutepcoritamab-byspGenmab A/S